Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

Quest Diagnostics…

USUSD
← Allo screener
US:DGXLSE:0KSX

Quest Diagnostics Incorporated (LSE:0KSX) — Medical Specialities. Numero di borse in cui sono quotate le azioni della società: 2. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'azienda

Sito web
questdiagnostics.com
Relazioni con gli investitori
ir.questdiagnostics.com/overview/default.aspx
Settore
Health Care · Medical Specialities
Sede centrale
Madison, United States
Amministratore delegato
Steve Rusckowski
Dipendenti
46 000
Fondata
1967
Quotata dal
29.01.2018 (LSE:0KSX)
Azioni in circolazione
110.37 Mln al 2026-07-15
Flottante
109.81 Mln
Capitalizzazione di mercato
25.21 Mld USD
Insider
0.43%
Investitori istituzionali
98.9%
Settore (SIC)
Services-Medical Laboratories
LEI
8MCWUBXQ0WE04KMXBX50
Payout ratio
34.2%
FCF
1.35 Mld USD
27%
Debito
6.38 Mld USD
3.7 anni di FCF
Serie di dividendi
22 a.
Utili, FCF e dividendi pagati — per i 12 mesi fino a 30.06.2026 (l'ultimo rapporto dell'azienda).
Descrizione

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Borse e ticker

BorsaTickerValutaPrezzoTipo
US USA StocksDGX principaleUSD230.81 +1.65%azioni ordinarie
LSE London Stock Exchange0KSX IOBUSD231.43 +0.00%azioni ordinarie

Prezzo su 3 mesi

3M1Y3Y5Y
giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

Ultimi 12 mesi, US:DGX: 3.38 USD (4 pag.)

Quest Diagnostics Incorporated (DGX) paga dividendi trimestralmente. Negli ultimi 12 mesi, sono stati pagati 3.38 USD per azione (pagamenti: 4). Questo rappresenta circa il 1.46% del prezzo attuale delle azioni. In base alla storia dei pagamenti, la prossima data ex-dividendo è prevista intorno al 05.01.2027. Storia dei dividendi ininterrotta: 22 anni.

Data exPagamentoImporto%TipoTicker
2026-10-062026-10-210.8600 USD0.4/1.5 %trimestraleUS:DGX
2026-07-082026-07-220.8600 USD0.4/1.4 %trimestraleUS:DGX
2026-04-062026-04-200.8600 USD0.4/1.4 %trimestraleUS:DGX
2026-01-132026-01-280.8000 USD0.3/1.4 %trimestraleUS:DGX
2025-10-032025-10-200.8000 USD0.3/≈1.4 %trimestraleUS:DGX
2025-07-072025-07-210.8000 USD0.3/≈1.4 %trimestraleUS:DGX
2025-04-072025-04-210.8000 USD0.3/≈1.4 %trimestraleUS:DGX

Notizie di questa settimana

Ancora nessuna notizia dal sito della società.

pubblicità

Principali azionisti

DetentoreQuotaAzioniData del rapporto
Blackrock Inc.8.4%9.28 Mln2026-06-30
Vanguard Capital Managem…6.55%7.23 Mln2026-06-30
Vanguard Portfolio Manag…5.55%6.13 Mln2026-06-30
State Street Corporation5%5.52 Mln2026-06-30
Price (T.Rowe) Associate…4.93%5.44 Mln2026-06-30
Boston Partners4.3%4.74 Mln2026-06-30
JPMORGAN CHASE & CO3.19%3.52 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.51 Mln2026-06-30
Geode Capital Management…2.84%3.14 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.6%2.87 Mln2026-06-30
Morgan Stanley2.23%2.46 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.17%2.4 Mln2026-06-30
Edgepoint Investment Gro…2.04%2.25 Mln2026-06-30
iShares Trust-iShares Co…1.33%1.47 Mln2026-08-31
Fidelity Concord Street…1.3%1.43 Mln2026-07-31
SPDR S&P 500 ETF TRUST-S…1.23%1.36 Mln2026-08-31
John Hancock Funds III-D…1.09%1.2 Mln2026-07-31
JPMorgan Trust II-JPMorg…1.04%1.15 Mln2026-06-30
T. Rowe Price Dividend G…1%1.11 Mln2026-06-30
John Hancock Funds III-D…0.96%1.06 Mln2026-07-31
DAVIS J E CAUSEY (Chief…≈0.13%142 4232026-03-04
DAVIS JAMES E (Chief Exe…≈0.11%122 4232026-09-01
DOHERTY CATHERINE T (Off…≈0.06%71 6242026-03-05
PREVOZNIK MICHAEL E (Gen…≈0.04%42 3372026-08-28
DEPPE MICHAEL J (Officer…≈0.03%35 1962026-03-04
SAMAD SAMER ABDUL (Chief…≈0.03%33 4782026-07-22
RING TIMOTHY M (Director…≈0.03%31 1402026-05-20
PFEIFFER GARY M (Directo…≈0.03%31 0052026-05-20
MAIN TIMOTHY L (Director…≈0.02%27 4602026-07-22
GREGG VICKY B (Director)≈0.02%18 3862026-07-22